Elsevier Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Hsu
    Hsu
  3. Kris
    Kris
  4. Berger
    Berger
  5. Giralt
    Giralt
  6. Perales
    Perales
  7. Riely
    Riely
  8. Hanash
    Hanash
  9. Peled
    Peled
  10. Solit
    Solit

Groups

  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)
  7. Center for Hematologic Malignancies (166)
  8. Hematologic Malignancies, Division of (151)
  9. Sloan Kettering Institute Postdocs (125)
  10. Bone Marrow Transplant (116)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (182)
  3. Review (14)
  4. Book Section (9)
  5. Editorial (8)
  6. Conference Paper (1)
  7. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)

More Groups

People
  1. Marc Ladanyi (97)
  2. Marcel Van Den Brink (61)
  3. Katharine Hsu (52)
  4. Mark Kris (44)
  5. Michael Berger (38)
  6. Miguel-Angel Perales (37)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (26)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (100)
  2. Journal of Thoracic Oncology (89)
  3. Urologic Oncology: Seminars and Original Investigations (31)
  4. European Journal of Cancer (30)
  5. International Journal of Radiation Oncology, Biology, Physics (18)
  6. Transplantation and Cellular Therapy (13)

More Publications

Results (420)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Deleterious alterations in DNA damage response genes are associated with improved outcome in muscle-invasive bladder cancer patients treated with radiation-based bladder preservation
    Meeting Abstract

    Desai, N. B.; Iyer, G. I.; Cha, E. K.; Scott, S. N.; Hreiki, J.; Sfakianos, J.; Bagrodia, A.; Bochner, B. H.; Rosenberg, J. E.; Bajorin, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Basaloid squamous cell cancers arising from the lung: Next generation sequencing reveals PTCH1 mutations in the hedgehog pathway
    Meeting Abstract

    Li, B. T.; Rekhtman, N.; Won, H.; Arcila, M. E.; Rudin, C. M.; Kris, M. G.; Berger, M.; Paik, P.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • BAP1 inactivation in mesothelioma is highly prevalent
    Meeting Abstract

    Zauderer, M.; Cercek, A.; Rimner, A.; Rusch, V.; Adusumilli, P. S.; Nash, G. M.; Moreira, A.; Hmeljak, J.; Ladanyi, M.; Krug, L. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive mutation analysis of never-smokers with small cell lung cancer (SCLC)
    Meeting Abstract

    Pietanza, M. C.; Won, H.; Krug, L. M.; Varghese, A. M.; Riely, G. J.; Rekhtman, N.; Wang, L.; Travis, W. D.; Zakowski, M.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Precision medicine at Memorial Sloan Kettering Cancer Center: Clinical next-generation sequencing enabling next-generation targeted therapy trials
    Journal Article

    Hyman, D. M.; Solit, D. B.; Arcila, M. E.; Cheng, D. T.; Sabbatini, P.; Baselga, J.; Berger, M. F.; Ladanyi, M.
    Drug Discovery Today (2015)

    Fulltext@MSK | Save
  • Impact of concurrent PIK3CA mutations on response to EGFR tyrosine kinase inhibition in EGFR-mutant lung cancers and on prognosis in oncogene-driven lung adenocarcinomas
    Journal Article

    Eng, J.; Woo, K. M.; Sima, C. S.; Plodkowski, A.; Hellmann, M. D.; Chaft, J. E.; Kris, M. G.; Arcila, M. E.; Ladanyi, M.; Drilon, A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive analyses of oncogenic driver fusions using the NanoString nCounter in lung adenocarcinoma from Japanese never- and light-smokers
    Meeting Abstract

    Takamochi, K.; Suehara, Y.; Mogushi, K.; Kohsaka, S.; Mano, H.; Takeuchi, K.; Saito, T.; Suzuki, K.; Ladanyi, M.; Takahashi, K.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Assessment of genomic alterations in bladder adenocarcinoma and urachal adenocarcinoma
    Meeting Abstract

    Jordan, E.; Won, H.; Toubaji, A.; Bagrodia, A.; Desai, N.; Bajorin, D.; Rosenberg, J.; Bochner, B.; Kim, W.; Berger, M.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save